Investing Profile

Carl Gordon

Photo of Carl Gordon, Managing Partner at OrbiMed
Your Intro Paths to Carl Gordon

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Carl Gordon on

cb
Current Investing Position
OrbiMed Managing Partner
Investment Range
$1M - $75.0M
Sweet Spot
$4.0M
Investments On Record
52
Current Fund Size
$18B

Carl Gordon is on these Sector & Stage Rankings

Carl Gordon's Investments On Record (27)

CompanyStageDateRound SizeTotal Raised
Alterome Therapeutics
Series ANov 2022$35M
Series AJan 2022$64M
$99M
Odyssey Therapeutics
Series BOct 2022$170M
Series ADec 2021$220M
$390M
Co-investors: Elena Viboch (General Catalyst), Jill carroll (SR One)
Electra Therapeutics
Series BFeb 2022$84M
$84M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Garuda Therapeutics
Series ASep 2021$72M
$72M
Co-investors: Shaan C. Gandhi (Northpond Ventures)
ADARx Pharmaceuticals
Series BSep 2021$75M
$75M
XinThera
Series BAug 2021$50M
$50M
Co-investors: Jim Tananbaum (Foresite Capital), Michael Rome (Foresite Capital)
Theseus Pharmaceuticals
Series BApr 2021$100M
$100M
Co-investors: Michael Rome (Foresite Capital)
Scribe Therapeutics
Series BMar 2021$100M
$120M
Co-investors: Vijay Pande (Andreessen Horowitz)